We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$30.1B
AUM Growth
+$3.82B
Cap. Flow
+$6.13B
Cap. Flow %
20.35%
Top 10 Hldgs %
39.75%
Holding
3,818
New
874
Increased
1,161
Reduced
890
Closed
844

Sector Composition

Rank Sector Weight
1 Technology 5.92%
2 Financials 4.33%
3 Healthcare 3.85%
4 Consumer Discretionary 3.59%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WW
2951
DELISTED
WW International
WW
$61.2K ﹤0.01%
117,100
FLNC icon
2952
CALL
Fluence Energy
FLNC
$1.55B
$59.2K ﹤0.01%
+12,200
New +$117K
DCGO icon
2953
DocGo
DCGO
$37.8M
$58.9K ﹤0.01%
22,329
ENTA icon
2954
Enanta Pharmaceuticals
ENTA
$411M
$57.1K ﹤0.01%
10,347
ZNTL icon
2955
Zentalis Pharmaceuticals
ZNTL
$356M
$55.4K ﹤0.01%
34,849
-320
-0.9% -$690
GOSS icon
2956
Gossamer Bio
GOSS
$85.5M
$51.1K ﹤0.01%
46,464
ALEC icon
2957
Alector
ALEC
$257M
$50.2K ﹤0.01%
40,796
TNGX icon
2958
Tango Therapeutics
TNGX
$4.13B
$46.7K ﹤0.01%
34,060
-26,554
-44% -$65.2K
GTN icon
2959
Gray Television
GTN
$507M
$46K ﹤0.01%
+10,659
New +$41.9K
TALK
2960
DELISTED
Talkspace
TALK
$46K ﹤0.01%
+17,960
New +$56K
MODV
2961
DELISTED
ModivCare
MODV
$44.3K ﹤0.01%
33,660
-15,465
-31% -$74.8K
CDXS icon
2962
Codexis
CDXS
$182M
$43.9K ﹤0.01%
16,332
-90,033
-85% -$349K
MCRB icon
2963
Seres Therapeutics
MCRB
$46.8M
$43.4K ﹤0.01%
3,099
PLRX icon
2964
Pliant Therapeutics
PLRX
$70.6M
$40.4K ﹤0.01%
+29,932
New +$182K
NKTR icon
2965
Nektar Therapeutics
NKTR
$2.52B
$38.8K ﹤0.01%
3,806
STEM icon
2966
Stem
STEM
$52.6M
$32.1K ﹤0.01%
4,580
APLT
2967
DELISTED
Applied Therapeutics
APLT
$28.1K ﹤0.01%
57,454
MGNX icon
2968
MacroGenics
MGNX
$256M
$20.9K ﹤0.01%
16,429
+5,479
+50% +$14.3K
AIMAW
2969
CALL
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$15.5K ﹤0.01%
200,000
CMBM
2970
DELISTED
Cambium Networks
CMBM
$15K ﹤0.01%
21,307
SLND.WS icon
2971
CALL
Southland Holdings Warrants
SLND.WS
$12K ﹤0.01%
75,000
AXDX
2972
DELISTED
Accelerate Diagnostics
AXDX
$9.89K ﹤0.01%
14,110
OCGN icon
2973
Ocugen
OCGN
$461M
$9.79K ﹤0.01%
13,865
IAUX
2974
i-80 Gold Corp
IAUX
$1.66B
$6.98K ﹤0.01%
12,000
AA icon
2975
CALL
Alcoa
AA
$13B
-72,900
Closed -$2.75M

Similar funds

Paul Tudor Jones's Q1 2025 Portfolio in Review

As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.

  • Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
  • Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
  • Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
  • Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
  • Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
  • Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
  • Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.

Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.